TYK349

FDA approved indications for the use of recombinant VIIa include which of the following:

a) Use in patients with severe blood loss associated with trauma.

b) Use in patients with congenital factor VII deficiency.

c) Use in patients with intracerebral hemorrhage.

d) Use in patients undergoing open cardiac surgery requiring cardiopulmonary bypass.

Click for Answer

Answer

Answer b. Currently the only FDA approved indications include use in patients with congenital factor VII deficiency and in patients with hemophilia.

Notes

This question originally printed in the Pediatric Anesthesiology Review Topics kindle book series, and appears courtesy of Naerthwyn Press, LLC.

Keywords

---

---

<Prev Question --- Next Question>

About Test Your Knowledge